Navigation Links
Collaboration of Indiana's Health Information Exchanges, State Organizations Submits Application for Health Information Technology Stimulus Funding
Date:10/16/2009

Led by BioCrossroads, effort focuses on Indiana's depth, breadth and leadership in HIT, advancing it to the next level

INDIANAPOLIS, Oct. 16 /PRNewswire-USNewswire/ -- In an unprecedented collaborative effort, the State of Indiana under Governor Mitch Daniels' leadership, and Indiana's five independent health information exchanges and four state organizations, spearheaded by BioCrossroads, submitted an application today to receive federal stimulus funding for a statewide health information technology (HIT) program. If awarded, several million dollars in funding would be provided by the American Recovery and Reinvestment Act's Cooperative Agreement Program (CAP) which will be used to further enhance the quality and reach of the State of Indiana's HIT delivery system.

The four-year grant would not only assist in advancing Indiana's position as a leader in sustainable, secure, standards-based health information exchange (HIE), which securely sends clinical test results, reports and other medical information, but would also improve the quality, safety, and efficiency of patient care statewide. If awarded the CAP funding, the State of Indiana will further develop a state governance structure to continue encouraging collaboration among health information exchanges, the state, and regional extension centers.

The newly formed governance organization, now known as Indiana Health Information Technology, Inc. (IHIT), will promote alliances and innovation among the State's five independent exchanges including:

  • HealthBridge
  • HealthLINC
  • Indiana Health Information Exchange (IHIE)
  • MedWeb
  • Michiana Health Information Network (MHIN)

as well as four state organizations:

  • Family and Social Services Administration
  • Indiana Department of Health
  • Indiana Economic Development Corporation
  • Indiana Health Informatics C
    '/>"/>

SOURCE BioCrossroads
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Irvine Scientific and Selexis to Announce Results of Successful Collaboration
2. goBalto Introduces Web-based Solution to Manage Drug-development Collaborations
3. InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis
4. New Collaborations and Breakthrough Advancements in RNA-Based Drug Development Programs Lead Santaris Pharma A/S to Establish US Operations
5. Pieris AG Enters into Anticalin Collaboration With Allergan, Inc.
6. Champions Biotechnology and PinnacleCare Enter Into Personalized Oncology Collaboration Agreement
7. Seahorse Bioscience to Present Novel Cellular Bioenergetics Data in Collaboration with University of Nebraska at AACR Metabolism and Cancer Conference
8. PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration
9. PTC Therapeutics Announces Drug Discovery Collaboration With Roche
10. ChemBridge Corporation and Collaborative Drug Discovery Announce Strategic Collaboration to Provide Diverse Chemical Libraries Together With Researchers Own Private Data
11. Over 60 Firms Confirmed to Attend CBIs Third Annual Bio/Pharmaceutical Collaboration and Transaction Accounting Conference in September
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 According ... Product (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity ... Development, Preclinical, Clinical Trial), by End Users - Global ... is expected to reach USD 2,107.99 million by 2020 ... of 15.29%. Browse more than ...
(Date:7/30/2015)... 2015   Aratana Therapeutics, Inc . (NASDAQ: ... on the licensing, development and commercialization of innovative ... its strategic partner VetStem Biopharma, Inc. has shared ... AT-016, an adipose-derived allogeneic stem cell product exclusively ... pain in dogs. The double-blinded, multi-site, ...
(Date:7/30/2015)...  With over 60,000 customers across the globe, ISN improves the efficiency and effectiveness ... more than 60,000 safe and reliable contractors in over 80 countries. ... ... Over 60,000 Worldwide Customers In ... Headquartered in Dallas, TX , ISN has additional ...
(Date:7/30/2015)... 30, 2015 HIGHLIGHTS:Q2 2015 Results ... , Reported sales were $697 million compared to ... grew organically by 8%, and changes in foreign currency ... sales by 1%. , By business unit, organic ... and 11% in SAFC Commercial. , Reported diluted ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
... to Focus on Specialty ... and Biotechnology, STAMFORD, Conn., April 21 Thomas, ... that invests in life science and,medical technology companies, today ... Entrepreneur-in-Residence in the firm,s Connecticut,office. Most recently, Dr. Tierney ...
... AB,(publ) has decided on, and successfully executed, a direct placement ... placed with a limited,group of professional investors at a price ... total for the Company before issue costs. For each,issued and ... which,gives the right to subscribe for a series B share ...
... and WINNERSH, England, April 21 Paul Capital,Healthcare ... they have,signed a financing agreement relating to frovatriptan, ... agreement, Vernalis will receive,approximately euro 18.4 million in ... Capital Healthcare will receive approximately 90 per cent,of ...
Cached Biology Technology:David S. Tierney, M.D., Joins Thomas, McNerney & Partners as Entrepreneur-In-Residence 2Diamyd Strengthens Financial Position and Executes a Fully Subscribed Direct Placement 2Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement 2Vernalis and Paul Capital Healthcare Sign euro 18.4 Million Financing Agreement 3
(Date:7/31/2015)... SHENZHEN , Chine, 31 juillet 2015 /PRNewswire/ ... (ICG-10, www.icg-10.org ) sera organisée par le ... Shenzhen en Chine. ... année. Depuis son inauguration en 2006, l,ICG est ... influentes dans le domaine des « omiques » et c,est ...
(Date:7/30/2015)... , July 30, 2015 Cellecta, Inc., ... gene function analysis and biomarker discovery, announced the ... Knockout Library targeting all human protein coding genes. ... "knock out" a gene,s function. Cellecta,s new Human ... throughput screening tool so that researchers can investigate ...
(Date:7/21/2015)... -- Today, ZTE announced its Android smartphone Axon, featuring ... revenues in 2015 that relate to sales of FPC1025 for this ... 2,200 MSEK for 2015. Jörgen Lantto, CEO of FPC, ... China and we are proud that ... Axon , its first ...
Breaking Biology News(10 mins):La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 2La 10e International Conference on Genomics (ICG-10) doit s'ouvrir en octobre 3CELLECTA, INC. Announces Launch of Human Whole Genome CRISPR Knockout Library 2FPC's Touch Fingerprint Sensor FPC1025 in ZTE's Smartphone Axon 2
... A team of Columbia University Medical Center (CUMC) ... found the first direct evidence of a link between ... hallmark of asthma. The study, conducted in mice, shows ... lung is forming can cause profound changes in the ...
... the subject of a symposium on Saturday, February 15, at the ... Science in Chicago. The session, which features two members of ... will take place 10:00-11:30 a.m. CST in Grand Ballroom B of ... 2014 winner of the Golden Goose Award will be ...
... Calif.) The rapid conversion of natural lands to cement-dominated ... to a new study involving 147 cities worldwide, surprisingly high ... in urban environments to the tune of hundreds of ... city. Contrary to conventional wisdom that cities are a ...
Cached Biology News:Prenatal vitamin A deficiency tied to postnatal asthma 2Prenatal vitamin A deficiency tied to postnatal asthma 3Cities support more native biodiversity than previously thought 2Cities support more native biodiversity than previously thought 3
... The SYS203 is a complete, flexible ... in small samples, as is frequently ... is designed around Instechs miniature Clark-style ... an inch in diameter (3.2 mm), ...
Yellow oily liquid. Contains 85% Drakeol 5NF, 15% Arlacel A (mannide monooleate emulsifier). Heat sterilized. Contains zero colony forming units/ml. ...
Sterile, Cell culture tested...
For removal of the zona pellucida. Sterile, Mouse Embryo tested...
Biology Products: